Literature DB >> 30507902

The Galleria mellonella Waxworm Infection Model for Disseminated Candidiasis.

Matthew J Dunn1, Andrew L Woodruff1, Matthew Z Anderson2.   

Abstract

Candida species are common fungal commensals of humans colonizing the skin, mucosal surfaces, and gastrointestinal tract. Under certain conditions, Candida can overgrow their natural niches resulting in debilitating mucosal infections as well as life-threatening systemic infections, which are a major focus of investigation due to their associated high mortality rates. Animal models of disseminated infection exist for studying disease progression and dissecting the characteristics of Candida pathogenicity. Of these, the Galleria mellonella waxworm infection model provides a cost-effective experimental tool for high-throughput investigations of systemic virulence. Many other bacterial and eukaryotic infectious agents have been effectively studied in G. mellonella to understand pathogenicity, making it a widely accepted model system. Yet, variation in the method used to infect G. mellonella can alter phenotypic outcomes and complicate interpretation of the results. Here, we outline the benefits and drawbacks of the waxworm model to study systemic Candida pathogenesis and detail an approach to improve reproducibility. Our results highlight the range of mortality kinetics in G. mellonella and describe the variables which can modulate these kinetics. Ultimately, this method stands as an ethical, rapid, and cost-effective approach to study virulence in a model of disseminated candidiasis.

Entities:  

Mesh:

Year:  2018        PMID: 30507902     DOI: 10.3791/58914

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  1 in total

1.  The design and implementation of restraint devices for the injection of pathogenic microorganisms into Galleria mellonella.

Authors:  Lance R Fredericks; Mark D Lee; Cooper R Roslund; Angela M Crabtree; Peter B Allen; Paul A Rowley
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.